Antipsychotics are the best defense against relapse in schizophrenia, even though that protection often comes at the expense ...

The worldwide growing occurrences of mental health disorders are significantly boosting the antipsychotic drugs market. An estimated 21% of U.S. adults have mental illness in 2023, which is over ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...

Bristol Myers Squibb's (BMY) new schizophrenia drug, Cobenfy, improves symptoms with a well-tolerated safety profile in two ...

Resulting data from 9,525 participants determined that while antipsychotics as a group showed slight cognitive benefits, no individual drug demonstrated a substantial advantage over placebo.

Addition of the antipsychotic lumateperone (Caplyta) to an existing antidepressant improved symptoms of depression in a ...

"Based on the evidence considered, no clear recommendation can be made for a specific antipsychotic medication," co-author Lena Feber, MSc, also of the Technical University of Munich School of ...

People with these symptoms are often prescribed antipsychotic drugs inappropriately. These may reduce experiences such as delusions, but they are also linked to serious side effects including ...

Two weeks earlier, Dr. Rab had persuaded Yoh to start an oral antipsychotic medication. Now the doctor wanted to go further. “One thing that can make your life a little bit easier,” he said.